cyclopentane has been researched along with Adenocarcinoma, Mucinous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardelli, A; Bertotti, A; Di Nicolantonio, F; Grillone, K; Isella, C; Medico, E; Migliardi, G; Petti, C; Picco, G; Rossi, T; Sapino, A; Sarotto, I; Sassi, F; Trusolino, L | 1 |
1 other study(ies) available for cyclopentane and Adenocarcinoma, Mucinous
Article | Year |
---|---|
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.
Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Apoptosis; Cadherins; CDX2 Transcription Factor; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colorectal Neoplasms; Cyclopentanes; Disease-Free Survival; DNA Replication; Drug Resistance, Neoplasm; Female; Homeodomain Proteins; Humans; Keratin-20; Mice; NEDD8 Protein; Neoplasm Grading; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction; Transcriptome; Ubiquitins | 2017 |